Scientists in the UK are working to develop a hand-held testing device to provide same day diagnosis from a patient’s bedside. The device will use disposable cartridges and utilise printed circuit board technology (PCB) that will allow a fast and low-cost diagnosis.
Sepsis kills around 130 patients daily In Germany alone. This systemic disease is mostly caused by bacterial pathogens, and less frequently by fungal organisms or parasites. Professor Dr Frank M Brunkhorst of the Centre of Sepsis Control and Care (CSCC), at Jena University Hospital, Germany, is seeking strategies to combat such scary figures.
Some years ago telepathology – a complex but well developed procedure where histology specimens are photographed using a camera mounted on a microscope and transmitted – was thought to be the wave of the future.
Having convinced medical labs across Denmark that its suite of image analysis software can provide a solution to the crushing burden of in vitro diagnostics (IVD), VisioPharm is offering it to pathologists worldwide
USA - Oocyte modification to eliminate inherited mitochondrial defects in a human embryo was the subject of a globally scrutinised Food and Drug Administration (FDA) hearing held in February.
This April, in San Jose, California, the portable lab took central stage at the American Association for Clinical Chemistry’s (AACC) annual forum for emerging clinical diagnostic technologies – a most appropriate topic for the Silicon Valley venue where so many world-changing computer and communications innovations have been born.
Two companies with similar core values, providing high quality products for acute care and point-of-care testing worldwide.
Postoperative infections after knee or hip joint replacements are among the most feared complications in orthopaedic surgery. At the EFORT Congress in London current research was presented that provides new insights in this field: Fracture patients are especially vulnerable to infection. New biomarkers should improve early diagnosis of risky infections.
Future of DNA sequencing will shift from a laboratory-based setup to point of care testing in the next 5 years
Reliable results can only be achieved in urine diagnostics, if correct preanalytical conditions are ensured. Urine collection, specimen transport and further storage are critical influential factors for sample quality and can affect the results.
‘Physicians and clinicians treating patients at the point of care (POC) can benefit greatly from easy access to materials and resources via their handheld devices,’ comments Jamie Gramz, Director of Global Marketing at Siemens Healthcare Diagnostics.
A small prick to sample blood instead of complex pathological or other diagnostic procedures – this is how early cancer diagnosis will be in the near future. Blood tests to diagnose tumorous diseases early are already being researched for clinical use.
"I can count on my fingers the number of pathologists who work full digitally," said Elin Kindberg who is leading the development of a pathology PACS for Sectra Imaging IT Solutions. Conventional light microscopes continued to be standard tool for examining histo-pathology slides.
You’ll find Élie Azoulay everywhere during this year’s International Symposium on Intensive Care and Emergency Medicine (ISICEM).
How do our brains combine information from the external world (sensory stimulation) with information on our internal state such as hunger, fear or stress?
‘The disease “cancer” is increasingly classified into sub-groups. Today, we are already dealing with a number of orphan diseases,’ says Professor Richard Greil MD, head of LIMCR at University Hospital Salzburg.
Olympus launches its OlyVIA Mobile iPad App, an image viewer dedicated to virtual slides.
Poor growth in the first three months of pregnancy is associated with a range of cardiovascular risk factors in childhood, finds a study published on bmj.com.
Offering attractive procurement strategies will boost adoption of high-end tools
Down’s syndrome (also referred to as trisomy 21) is a genetic disorder caused by the presence of all or part of an extra copy of chromosome 21 in a person’s DNA. Current screening for Down’s syndrome and other trisomy conditions includes a combined test done between the 11th and 13th weeks of pregnancy.
Over the past decade the use of point-of-care testing (POCT) in European and North American hospitals has steadily increased, stimulated by the objectives of accelerating diagnostic treatment, increasing efficiency and improving patient outcomes.
Ahead of regulatory approval that is expected before the end of the year, Trinity Biotech chose Medica to present the novel point-of-care (POC) analyzer Meritas with the Troponin I (TnI) that are expected to disrupt a €700 million market.
The properties of copper in helping prevent nosocomial infections were debated this October at the Infection Prevention 2013 conference, when Professor Tom Elliott, Consultant Microbiologist at University Hospitals Birmingham NHS Foundation Trust, addressed the question: ‘Can the use of copper help prevent infection?’
Over the past 10 years the use of point-of-care testing (POCT) in in European and North American hospitals has steadily increased, stimulated by the objectives of accelerating diagnostic treatment, increasing efficiency and improving patient outcomes, Cynthia E. Keen reports
Using electrically conductive, ink-like materials, a Swedish consortium has created a fully functional prototype for a self-monitoring blood glucose (SMBG) test that could be disruptive for in vitro diagnostics.
